Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration

Alessandro Sartorio, Anna Spada, Domenico Bochicchio, Antonio Atterrato, Francesco Morabito, Giovanni Faglia

Research output: Contribution to journalArticle

Abstract

Growth hormone (GH) increase after thyrotropin-releasing hormone (TRH) has been documented in many pathological conditions. In order to evaluate whether exposure to growth hormone-releasing factor (GRF) might contribute to this effect in normal subjects, we studied GH responses to placebo, TRH, GRF and GRF plus TRH either in basal condition or after GRF administration. Ten subjects received placebo, TRH, GRF and GRF plus TRH on four separate occasions. GRF induced a clear rise in plasma GH, statistically different from those obtained after placebo or TRH (p <0.01). TRH was completely ineffective in both stimulating GH release and amplifying the secretory GH response to GRF. Twenty subjects, subdivided in four groups, received 3 consecutive intravenous GRF boli at two-hour intervals. Two hours later they were given a fourth stimulus: 5 had another 25 μg GRF i.v., 5 had 200 μg TRH i.v., 5 were tested with simultaneous 25 μg GRF and 200 μg TRH i.v. injection, and 5 with 1 ml saline. GH secretory responses were quantitated by determining the net incremental area under the curve (nAUC) over 60 min after the administration of each stimulus. The pattern of GH secretion after 1-3 GRF boli was not statistically different among the four groups. Plasma GH nAUC was higher after the first GRF injection than after the following ones (p <0.01). The administration of a fourth GRF bolus also caused a GH increase which was significantly smaller than that after the first one (p <0.01), but greater than that after placebo (p <0.01). Contrary to the data observed in the basal condition, TRH injection caused a small but significant increase of GH versus placebo (p <0.01). GRF and TRH combined administration induced a greater GH response than those recorded after each single agent (p <0.05 vs. GRF; p <0.01 vs. TRH). No significant modifications in plasma somatostatin levels were observed after the administration of multiple GRF stimuli and combined GRF plus TRH.

Original languageEnglish
Pages (from-to)470-474
Number of pages5
JournalNeuroendocrinology
Volume44
Issue number4
DOIs
Publication statusPublished - 1986

Fingerprint

Growth Hormone-Releasing Hormone
Thyrotropin-Releasing Hormone
Growth Hormone
Placebos
Injections
Area Under Curve

Keywords

  • GH
  • GRF
  • Growth hormone
  • Growth hormone-releasing factor
  • Thyrotropin-releasing hormone
  • TRH

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Cellular and Molecular Neuroscience
  • Endocrine and Autonomic Systems
  • Neuroscience(all)

Cite this

Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration. / Sartorio, Alessandro; Spada, Anna; Bochicchio, Domenico; Atterrato, Antonio; Morabito, Francesco; Faglia, Giovanni.

In: Neuroendocrinology, Vol. 44, No. 4, 1986, p. 470-474.

Research output: Contribution to journalArticle

Sartorio, Alessandro ; Spada, Anna ; Bochicchio, Domenico ; Atterrato, Antonio ; Morabito, Francesco ; Faglia, Giovanni. / Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration. In: Neuroendocrinology. 1986 ; Vol. 44, No. 4. pp. 470-474.
@article{077432f2afcd4bbd8e618c540d7432ff,
title = "Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration",
abstract = "Growth hormone (GH) increase after thyrotropin-releasing hormone (TRH) has been documented in many pathological conditions. In order to evaluate whether exposure to growth hormone-releasing factor (GRF) might contribute to this effect in normal subjects, we studied GH responses to placebo, TRH, GRF and GRF plus TRH either in basal condition or after GRF administration. Ten subjects received placebo, TRH, GRF and GRF plus TRH on four separate occasions. GRF induced a clear rise in plasma GH, statistically different from those obtained after placebo or TRH (p <0.01). TRH was completely ineffective in both stimulating GH release and amplifying the secretory GH response to GRF. Twenty subjects, subdivided in four groups, received 3 consecutive intravenous GRF boli at two-hour intervals. Two hours later they were given a fourth stimulus: 5 had another 25 μg GRF i.v., 5 had 200 μg TRH i.v., 5 were tested with simultaneous 25 μg GRF and 200 μg TRH i.v. injection, and 5 with 1 ml saline. GH secretory responses were quantitated by determining the net incremental area under the curve (nAUC) over 60 min after the administration of each stimulus. The pattern of GH secretion after 1-3 GRF boli was not statistically different among the four groups. Plasma GH nAUC was higher after the first GRF injection than after the following ones (p <0.01). The administration of a fourth GRF bolus also caused a GH increase which was significantly smaller than that after the first one (p <0.01), but greater than that after placebo (p <0.01). Contrary to the data observed in the basal condition, TRH injection caused a small but significant increase of GH versus placebo (p <0.01). GRF and TRH combined administration induced a greater GH response than those recorded after each single agent (p <0.05 vs. GRF; p <0.01 vs. TRH). No significant modifications in plasma somatostatin levels were observed after the administration of multiple GRF stimuli and combined GRF plus TRH.",
keywords = "GH, GRF, Growth hormone, Growth hormone-releasing factor, Thyrotropin-releasing hormone, TRH",
author = "Alessandro Sartorio and Anna Spada and Domenico Bochicchio and Antonio Atterrato and Francesco Morabito and Giovanni Faglia",
year = "1986",
doi = "10.1159/000124688",
language = "English",
volume = "44",
pages = "470--474",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Effect of thyrotropin-releasing hormone on growth hormone release in normal subjects pretreated with human pancreatic growth hormone-releasing factor 1-44 pulsatile administration

AU - Sartorio, Alessandro

AU - Spada, Anna

AU - Bochicchio, Domenico

AU - Atterrato, Antonio

AU - Morabito, Francesco

AU - Faglia, Giovanni

PY - 1986

Y1 - 1986

N2 - Growth hormone (GH) increase after thyrotropin-releasing hormone (TRH) has been documented in many pathological conditions. In order to evaluate whether exposure to growth hormone-releasing factor (GRF) might contribute to this effect in normal subjects, we studied GH responses to placebo, TRH, GRF and GRF plus TRH either in basal condition or after GRF administration. Ten subjects received placebo, TRH, GRF and GRF plus TRH on four separate occasions. GRF induced a clear rise in plasma GH, statistically different from those obtained after placebo or TRH (p <0.01). TRH was completely ineffective in both stimulating GH release and amplifying the secretory GH response to GRF. Twenty subjects, subdivided in four groups, received 3 consecutive intravenous GRF boli at two-hour intervals. Two hours later they were given a fourth stimulus: 5 had another 25 μg GRF i.v., 5 had 200 μg TRH i.v., 5 were tested with simultaneous 25 μg GRF and 200 μg TRH i.v. injection, and 5 with 1 ml saline. GH secretory responses were quantitated by determining the net incremental area under the curve (nAUC) over 60 min after the administration of each stimulus. The pattern of GH secretion after 1-3 GRF boli was not statistically different among the four groups. Plasma GH nAUC was higher after the first GRF injection than after the following ones (p <0.01). The administration of a fourth GRF bolus also caused a GH increase which was significantly smaller than that after the first one (p <0.01), but greater than that after placebo (p <0.01). Contrary to the data observed in the basal condition, TRH injection caused a small but significant increase of GH versus placebo (p <0.01). GRF and TRH combined administration induced a greater GH response than those recorded after each single agent (p <0.05 vs. GRF; p <0.01 vs. TRH). No significant modifications in plasma somatostatin levels were observed after the administration of multiple GRF stimuli and combined GRF plus TRH.

AB - Growth hormone (GH) increase after thyrotropin-releasing hormone (TRH) has been documented in many pathological conditions. In order to evaluate whether exposure to growth hormone-releasing factor (GRF) might contribute to this effect in normal subjects, we studied GH responses to placebo, TRH, GRF and GRF plus TRH either in basal condition or after GRF administration. Ten subjects received placebo, TRH, GRF and GRF plus TRH on four separate occasions. GRF induced a clear rise in plasma GH, statistically different from those obtained after placebo or TRH (p <0.01). TRH was completely ineffective in both stimulating GH release and amplifying the secretory GH response to GRF. Twenty subjects, subdivided in four groups, received 3 consecutive intravenous GRF boli at two-hour intervals. Two hours later they were given a fourth stimulus: 5 had another 25 μg GRF i.v., 5 had 200 μg TRH i.v., 5 were tested with simultaneous 25 μg GRF and 200 μg TRH i.v. injection, and 5 with 1 ml saline. GH secretory responses were quantitated by determining the net incremental area under the curve (nAUC) over 60 min after the administration of each stimulus. The pattern of GH secretion after 1-3 GRF boli was not statistically different among the four groups. Plasma GH nAUC was higher after the first GRF injection than after the following ones (p <0.01). The administration of a fourth GRF bolus also caused a GH increase which was significantly smaller than that after the first one (p <0.01), but greater than that after placebo (p <0.01). Contrary to the data observed in the basal condition, TRH injection caused a small but significant increase of GH versus placebo (p <0.01). GRF and TRH combined administration induced a greater GH response than those recorded after each single agent (p <0.05 vs. GRF; p <0.01 vs. TRH). No significant modifications in plasma somatostatin levels were observed after the administration of multiple GRF stimuli and combined GRF plus TRH.

KW - GH

KW - GRF

KW - Growth hormone

KW - Growth hormone-releasing factor

KW - Thyrotropin-releasing hormone

KW - TRH

UR - http://www.scopus.com/inward/record.url?scp=0022998647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022998647&partnerID=8YFLogxK

U2 - 10.1159/000124688

DO - 10.1159/000124688

M3 - Article

C2 - 3102991

AN - SCOPUS:0022998647

VL - 44

SP - 470

EP - 474

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 4

ER -